Cross Country Healthcare (CCRN) Invested Capital (2010 - 2026)

Cross Country Healthcare has reported Invested Capital for 17 years, with the latest figure at $312.8 million in Q1 2026.

• For the quarter ending Q1 2026, Invested Capital fell 25.2% year-over-year to $312.8 million; the trailing twelve-month figure through Mar 2026 stood at $312.8 million (down 25.2% YoY), and the FY2025 full-year result was $322.8 million, down 23.75% from the prior year.
• Invested Capital for Q1 2026 stood at $312.8 million, down from $322.8 million in the prior quarter.
• The five-year high for Invested Capital was $480.4 million in Q2 2023, with the low at $312.8 million in Q1 2026.
• Historically, Invested Capital has averaged $422.3 million across 5 years, with a median of $423.4 million in 2024.
• Annual changes were most pronounced in 2022 — Invested Capital soared 113.91% — and 2026, when it slipped 25.2%.
• Cross Country Healthcare's Invested Capital stood at $459.0 million in 2022, then rose by 3.37% to $474.4 million in 2023, then declined by 10.77% to $423.4 million in 2024, then retreated by 23.75% to $322.8 million in 2025, then retreated by 3.1% to $312.8 million in 2026.
• The last three Invested Capital figures came in at $312.8 million (Q1 2026), $322.8 million (Q4 2025), and $408.1 million (Q3 2025), per Business Quant data.